ArticlePharmaceuticals (Basel, Switzerland)2022

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs.

Lukas von Bredow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.